466 filings
Page 18 of 24
8-K
xuvqggp
11 Mar 14
NewLink Genetics Corporation Reports Fourth Quarter and Year End 2013 Financial Results
12:00am
8-K
nsq9k
7 Mar 14
Other Events
12:00am
CT ORDER
cgmi4m
25 Feb 14
Confidential treatment order
12:00am
8-K
kcwvb1n6y ydku0inknu
25 Feb 14
Other Events
12:00am
8-K
mmfg9lu
8 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
ry3wgrfb c8s
6 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
h5c61i17
19 Dec 13
NewLink Genetics Launches Phase 1 Clinical Trial of Its HyperAcuteTM Renal Immunotherapy in Patients with Metastatic Renal Cell Cancer
12:00am
8-K
w44j1beg3jz
10 Dec 13
Other Events
12:00am
8-K
4b862wj h6li
14 Nov 13
Departure of Directors or Certain Officers
12:00am
8-K
0pmw92kmv5cvy bltv2
12 Nov 13
NewLink Genetics Corporation Reports Third Quarter 2013 Financial Results
12:00am
CT ORDER
phawxdzb
30 Sep 13
Confidential treatment order
12:00am
8-K
4o7wrh3bk0ziccxi06
30 Sep 13
NewLink Genetics Presents Data Demonstrating Potential Chemo-sensitization Activity of its HyperAcute™ Cancer Immunotherapy Product Candidates
12:00am
8-K
n4w0aokg
26 Sep 13
BioCentury NewsMakers in the Biotech Industry 2013 New York City
12:00am
8-K
vaf7kwq29yr6f496xke0
17 Sep 13
NewLink Genetics Completes Patient Enrollment in Phase 3 Algenpantucel-L (IMPRESS) Clinical Study
12:00am
8-K
oina9
12 Sep 13
NewLink Genetics to Present Data on Cancer Immunotherapy Programs
12:00am
8-K
c8igy
5 Sep 13
Entry into a Material Definitive Agreement
12:00am
424B5
us9r6 n0dl3s8k
5 Sep 13
Prospectus supplement for primary offering
12:00am
8-K
gg66ambjijnvr2w
14 Aug 13
Departure of Directors or Certain Officers
12:00am